Pharmaceutical compositions containing famotidine and aluminum hydroxide or magnesium hydroxide

  • US 5,817,340 A
  • Filed: 11/25/1996
  • Issued: 10/06/1998
  • Est. Priority Date: 12/01/1992
  • Status: Expired due to Term
First Claim
Patent Images

1. A solid oral dosage form for the treatment of gastrointestinal disorders comprising a therapeutically effective amount of impermeably coated famotidine granules for the treatment of gastric disorders and pharmacologically acceptable salts thereof;

  • and a therapeutically effective amount of aluminum hydroxide or magnesium hydroxide wherein the oral dosage form has said coated famotidine granules and the aluminum hydroxide or magnesium hydroxide in contact with each other, but separated by said impermeable coating on the famotidine granules which is impermeable to the aluminum hydroxide or magnesium hydroxide.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×